. VACASAN® (TULATHROMYCIN INJECTION) INJECTABLE SOLUTION 100 MG/ML 100 ML (RX) - Animal Health International, Inc.

VACASAN® (TULATHROMYCIN INJECTION) INJECTABLE SOLUTION 100 MG/ML 100 ML (RX)

VACASAN® (TULATHROMYCIN INJECTION) INJECTABLE SOLUTION 100 MG/ML 100 ML (RX)

Images may not accurately represent the product. Please order product based on its description.

Material #: 21313746
Manufacturer: HUVEPHARMA INC
Mfr #: JAVA-00003
UoM: BO
Scale: 10 Bottle per 1 Package
100 ml per 1 Bottle
2560 Bottle per 1 Pallet
80 Bottle per 1 Case
  • Prescription Drug
  • Non-Return

Logon for Price

  • Description
  • VACASAN® (tulathromycin injection) Injectable Solution is for use in
    beef cattle (including suckling calves), non-lactating dairy cattle
    (including dairy calves), veal calves, and swine. Not for use in female
    dairy cattle 20 months of age or older.

    Beef and Non-Lactating Dairy Cattle
    ▪BRD – VACASAN Injectable Solution is indicated for the treatment of
    bovine respiratory disease (BRD) associated with Mannheimia haemolytica,
    Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for
    the control of respiratory disease in cattle at high risk of developing
    BRD associated with Mannheimia haemolytica, Pasteurella multocida,
    Histophilus somni, and Mycoplasma bovis.
    ▪IBK – VACASAN Injectable Solution is indicated for the treatment of
    infectious bovine keratoconjunctivitis (IBK) associated with Moraxella
    bovis.
    ▪Foot Rot – VACASAN Injectable Solution is indicated for the treatment
    of bovine foot rot (interdigital necrobacillosis) associated with
    Fusobacterium necrophorum and Porphyromonas levii.

    Suckling Calves, Dairy Calves, and Veal Calves
    ▪BRD – VACASAN Injectable Solution is indicated for the treatment of BRD
    associated with M. haemolytica, P. multocida, H. somni, and M. bovis.

    Swine
    ▪VACASAN Injectable Solution is indicated for the treatment of swine
    respiratory disease (SRD) associated with Actinobacillus
    pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica,
    Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control
    of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella
    multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has
    been diagnosed.